Education
About Us
Working with TipRanks
Follow Us
InfuSystem Holdings, Inc. (INFU)
:INFU
INFU Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.61 - $11.04
Previous CloseN/A
Volume2.40K
Average Volume (3M)301.74K
Market Cap
$209.37M
Enterprise Value$161.13M
Total Cash (Recent Filing)$720.00K
Total Debt (Recent Filing)$30.45M
Price to Earnings (P/E)43.2
Beta1.59
Next Earnings
Nov 11, 2025EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.12
Shares Outstanding20,425,964
10 Day Avg. Volume264,695
30 Day Avg. Volume301,742
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.77
Enterprise Value/Revenue1.15
Enterprise Value/Gross Profit2.11
Enterprise Value/Ebitda6.77
Forecast
1Y Price Target
$13.38Price Target Upside30.54% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe Company showed notable progress in gross margin improvement of 122 basis points Y/Y and AEBITDA margin improvement of 282 basis points Y/Y.
Operating Cash FlowOperating cash flow was $20.5M in 2024, an 82% increase Y/Y.
Bears Say
EarningsEPS of $0.04 was below our estimate and consensus of $0.08 and $0.09, respectively.
RevenueRevenue came in below our forecast and consensus due to delays in onboarding new wound care initiatives as the Company looks to improve referral processes with newer partners.
InfuSystem Holdings News
INFU FAQ
What was InfuSystem Holdings, Inc.’s price range in the past 12 months?
InfuSystem Holdings, Inc. lowest stock price was $4.61 and its highest was $11.04 in the past 12 months.
What is InfuSystem Holdings, Inc.’s market cap?
InfuSystem Holdings, Inc.’s market cap is $209.37M.
When is InfuSystem Holdings, Inc.’s upcoming earnings report date?
InfuSystem Holdings, Inc.’s upcoming earnings report date is Nov 11, 2025 which is in 46 days.
How were InfuSystem Holdings, Inc.’s earnings last quarter?
InfuSystem Holdings, Inc. released its earnings results on Aug 05, 2025. The company reported $0.12 earnings per share for the quarter, beating the consensus estimate of $0.036 by $0.084.
Is InfuSystem Holdings, Inc. overvalued?
According to Wall Street analysts InfuSystem Holdings, Inc.’s price is currently Undervalued.
Does InfuSystem Holdings, Inc. pay dividends?
InfuSystem Holdings, Inc. does not currently pay dividends.
What is InfuSystem Holdings, Inc.’s EPS estimate?
InfuSystem Holdings, Inc.’s EPS estimate is 0.08.
How many shares outstanding does InfuSystem Holdings, Inc. have?
InfuSystem Holdings, Inc. has 20,425,964 shares outstanding.
What happened to InfuSystem Holdings, Inc.’s price movement after its last earnings report?
InfuSystem Holdings, Inc. reported an EPS of $0.12 in its last earnings report, beating expectations of $0.036. Following the earnings report the stock price went up 3.761%.
Which hedge fund is a major shareholder of InfuSystem Holdings, Inc.?
Currently, no hedge funds are holding shares in INFU
InfuSystem Holdings Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.38 (30.54% Upside)
$13.38 (30.54% Upside)
Blogger Sentiment
Bullish
INFU Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 10.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 39.5%
Last 30 Days ▲ 39.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
64.00%
12-Months-Change
Fundamentals
Return on Equity
9.39%
Trailing 12-Months
Asset Growth
-7.07%
Trailing 12-Months
Company Description
InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (INFU) is a leading provider of infusion pumps and related services, primarily serving the healthcare sector. The company specializes in the rental and sale of infusion pumps, as well as providing a comprehensive suite of services, including maintenance, logistics, and patient support. InfuSystem's core products cater to various medical applications, including pain management, chemotherapy, and antibiotic therapies, making it an essential partner for hospitals, clinics, and home healthcare providers.
INFU Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with strong financial performance and strategic initiatives leading to improved margins and cash flow. However, challenges in revenue growth outlook and specific business segments like Advanced Wound Care and ChemoMouthpiece tempered the positive aspects.View all INFU earnings summariesINFU Stock 12 Month Forecast
Average Price Target
$13.38
▲(30.54% Upside)
Technical Analysis
Stereotaxis
―
Utah Medical Products
―
Milestone Scientific
―
REPRO-MED Systems
―
Sanara MedTech
―
Ownership Overview
9.78% Insiders
18.23% Mutual Funds
38.40% Other Institutional Investors
27.81% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---